HistoGenetics is a New York-based biotech firm specializing in HLA Sequence Based Typing (SBT) services for blood cell transplants. Using cutting-edge robotics, software, and facilities, the company offers a suite of tissue-typing services with stringent quality assurance and swift turnaround times. Since its establishment in 2006, HistoGenetics has been a pioneer in HLA sequencing, delivering millions of cost-effective HLA SBT for various medical entities including donor registries, pharmacogenomics, donor centers, cord blood typing, transplant centers, and HLA laboratories. In addition to HLA, the company also provides molecular tissue typing services for other immunologically significant genes. The corporate office is situated in Ossining, New York, USA, with an additional Bioinformatics and IT Development center located in Chennai, India.
General Information
Get notified when HistoGenetics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track HistoGenetics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About HistoGenetics
Taxonomy: Biotech, HLA Sequencing, Tissue Typing, Immunogenetics, Molecular Typing, Pharmacogenomics, Donor Registries, Transplant Services, Bioinformatics, IT Development, NGS Analysis, Genomic Sequencing, Robotics, Engraftment Monitoring
No funding data available for HistoGenetics yet.
Get notified when HistoGenetics raises fundingHistoGenetics Alternatives & Competitors
Help Someone Else, Become a Blood Donor
Our mission is to save and enhance lives through the healing power of human cells and tissue.
Empowering healthcare facilities worldwide with innovative information management software solutions...
FAQ About HistoGenetics
Don't just browse. Track.
Signal Tracker monitors HistoGenetics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.